Greenphire
Greenphire provides patient payment and travel logistics technology for clinical trials, serving pharmaceutical sponsors, CROs, and research sites globally. Following its 2025 merger with Suvoda, it operates within a unified clinical trial technology platform spanning RTSM, eCOA, patient apps, and AI-enabled workflows.
- Company typePrivate
- Founded2007
- HeadquartersKing Of Prussia, United States
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What Greenphire does
Greenphire, founded in 2007 and headquartered near Philadelphia, Pennsylvania, built its business around clinical trial patient payments and travel logistics for pharmaceutical sponsors, contract research organizations (CROs), and clinical trial research sites. In February 2024, Greenphire acquired Clincierge to extend its concierge travel and patient support capabilities, and in 2025 the company merged with Suvoda to form a unified clinical trial technology platform. Following the merger, Greenphire Patient Payments and Greenphire Travel continue as branded product lines within the Suvoda platform, which now spans interactive response technology (RTSM/IRT), electronic clinical outcome assessments (eCOA), electronic consent (eConsent), scheduling, site payments, and budgeting and benchmarking. The combined platform reports 6,000+ trials conducted across 115+ countries and a 34% share of trials that received FDA approval since 2024, with roughly 65% of trials concentrated in oncology, rare disease, and CNS indications.
The technology stack follows a platform-plus-modules architecture centered on RTSM/IRT, augmented by eCOA, eConsent, site payments, and budgeting modules. Recent investment has focused on AI: Sofia, an AI assistant deployed within the IRT platform to reduce administrative burden on study teams, and an agentic RTSM capability that the company positions as enabling deployment from kickoff to user acceptance testing in as little as two weeks. A unified patient-facing mobile application consolidates scheduling, questionnaires, travel details, receipt submission, and reimbursement tracking into a single interface, addressing a well-documented fragmentation problem in trial participant experience. The technology is backed by five granted platform architecture patents and has been recognized externally, including a consecutive-year Leader designation in Everest Group's 2025 RTSM PEAK Matrix and a 2026 MedTech Breakthrough award for the Patient App.
Greenphire operates an enterprise SaaS business model: revenue is generated through multi-year subscription licensing of the platform and its modules to pharmaceutical sponsors and CROs, with quote-based pricing initiated via a 'Request a Demo' engagement model. Distribution is exclusively direct enterprise field sales, supported by a content-led demand generation funnel (blog, The ClinTech Podcast, webinars, case studies, industry events) and a dedicated CRO partnership program. The company has no public pricing and no self-serve channel, consistent with regulated, mission-critical enterprise software economics in life sciences.
Greenphire firmographics
Firmographics- Name
- Greenphire
- Legal name
- Greenphire LLC
- Website
- https://greenphire.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Acquired
- Headcount range
- 251–500 employees
- Short description
- Greenphire provides patient payment and travel logistics technology for clinical trials, serving pharmaceutical sponsors, CROs, and research sites globally. Following its 2025 merger with Suvoda, it operates within a unified clinical trial technology platform spanning RTSM, eCOA, patient apps, and AI-enabled workflows.
- Ownership category
- akta.pro rank
Greenphire industry classification
Industry- Product category
- Clinical Trial Technology Software
- NAICS
- Computer Systems Design and Related Services (5415), Computer Systems Design Services (541512), Other Computer Related Services (541519), Scientific Research and Development Services (5417)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373), Services-Health Services (8000)
- akta.pro primary industry
- Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL)
- akta.pro secondary industries
- Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH), Clinical Trial Supply, Logistics & Vendor Management FSP (HLAGAOAH)
Keywords
Where Greenphire is headquartered
LocationHeadquarters
- HQ city
- King Of Prussia
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Greenphire business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Enterprise SaaS Platform Subscriptions: Subscription-based licensing of the clinical trial technology platform (RTSM/IRT, eCOA, eConsent, patient payments, travel, scheduling, site payments) to pharmaceutical sponsors and CROs. Enterprise agreements with pharmaceutical companies and CROs, consistent with multi-year contractual subscriptions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise subscription pricing for pharmaceutical sponsors and CROs |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Greenphire product offering
Product offeringCore offering
Greenphire provides a clinical trial technology platform focused on patient payments, reimbursement management, and concierge travel and logistics support for clinical trial participants. Following its 2025 merger with Suvoda, the offering is delivered as part of a unified platform covering RTSM/IRT, eCOA, eConsent, patient payments, patient travel, scheduling, and site payments sold via enterprise SaaS subscriptions to pharmaceutical sponsors and CROs.
Product overview
Greenphire operates as part of the unified Suvoda clinical trial technology platform following the 2025 merger. The platform follows a platform-plus-modules architecture centered on RTSM (Interactive Response Technology) as the core product, augmented by eCOA and eConsent modules for data collection and compliance. Patient-facing solutions include the Greenphire Patient Payments and Greenphire Patient Travel products (acquired brands now integrated into the platform), alongside a unified Patient App that consolidates scheduling, questionnaires, travel details, and payment management. Supporting modules cover Site Payments and Budgeting & Benchmarking. The platform serves pharmaceutical sponsors and CROs across 115+ countries, with over 6,000 trials conducted including 65% in oncology, rare disease, and CNS.
Differentiator
Problem solved
Functional benefit
Brands
- Greenphire Patient Payments: Patient payment solution for clinical trials
- Greenphire Travel
Products and services
- Greenphire Patient Payments Digital payment management solution for clinical trial participants, handling reimbursement tracking and receipt submission for sponsors, CROs, and research sites.
- Greenphire Travel Concierge travel and logistics coordination service for clinical trial participants, supporting travel arrangements, logistics, and participant convenience across global trials.
- Clinical Trial Technology Platform
Quantifiable outcome
- 6,000+ clinical trials conducted on the platform, with 65% in oncology, rare disease, and CNS
- +4 more outcomes
Companies that use Greenphire
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
Greenphire technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature10 records
Greenphire partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ClinciergecoreGreenphire announced the acquisition of Clincierge, a provider of concierge travel and logistics support for clinical trial participants. The acquisition was completed on February 1, 2024, and was designed to enhance clinical trial support services by integrating patient care and technology. The deal aimed to improve participant experience, streamline trial processes, and expand service offerings for pharmaceutical companies and CROs globally.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Greenphire competitors and assessment
Company assessmentOthers
- Veeva Vault CTMS / eTMF: Adjacent life sciences clinical content and process management offerings from Veeva that, while not direct DCT rivals, share the same enterprise pharma buyer and increasingly overlap with the broader unified clinical platform.
Broad incumbents
- Veeva Systems: Broad life-sciences cloud incumbent serving pharmaceutical sponsors with overlapping capabilities in clinical operations, regulatory, and quality, alongside its core CRM/commercial offerings — competing with Suvoda/Greenphire on enterprise clinical platforms.
- IQVIA: Large CRO and health data analytics firm with clinical trial technology offerings (eCOA, RTSM, decentralized trials) that compete head-to-head with Greenphire's unified DCT platform, often bundled with CRO services.
- Oracle Health Sciences: Broad incumbent offering EDC, eClinical, and clinical trial platforms (inheriting Phase Forward and Oracle Clinical) — competing with Greenphire/Suvoda on integrated trial technology for large pharma.
Emerging players
- ArisGlobal: Life sciences technology vendor with clinical trial, safety, and regulatory platforms (including its LifeSphere CTMS/EDC/eCOA suite) — competing with Greenphire/Suvoda in mid-market and enterprise pharma.
- Medrio: Mid-market EDC and eClinical SaaS provider with eCOA and DCT offerings overlapping with Greenphire's patient-facing and data capture capabilities — particularly relevant for smaller biotech sponsors.
- Castor: Cloud-based EDC and DCT platform serving academic and commercial sponsors with patient-centric trial capabilities — competes with Greenphire on unified patient experience and decentralized trial enablement.
Direct peers
- Medidata (Dassault Systèmes): Direct competitor in RTSM/IRT, eCOA, eConsent, and clinical trial technology platforms serving the same pharmaceutical sponsor and CRO buyers. Medidata is the long-standing market leader in this category, making it the most direct comparable.
- Signant Health: Direct competitor formed from the merger of CRF Health and Bracket, specializing in eCOA, RTSM, patient engagement, and clinical supplies — closely comparable to Greenphire's patient payments, travel, and eCOA capabilities.
- Clario: Direct competitor offering eCOA, RTSM, cardiac safety, and imaging solutions for clinical trials — overlapping with Greenphire/Suvoda on the patient-facing and randomization/supply side of the platform.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Greenphire social profiles
Digital presenceGreenphire financial estimates
Financial estimateRevenue estimate
Valuation estimate
Greenphire leadership team
Management profileNumber of profiles
Profiles5 records
Greenphire subsidiaries and ownership
Company hierarchySubsidiaries1 record
Greenphire funding detail
Funding detailFunding overview
Funding rounds4 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Greenphire M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Greenphire
What does Greenphire do?
Greenphire provides a clinical trial technology platform focused on patient payments, reimbursement management, and concierge travel and logistics support for clinical trial participants. Following its 2025 merger with Suvoda, the offering is delivered as part of a unified platform covering RTSM/IRT, eCOA, eConsent, patient payments, patient travel, scheduling, and site payments sold via enterprise SaaS subscriptions to pharmaceutical sponsors and CROs.
Is Greenphire a public or private company?
Greenphire is a private company. It is classified as corporate owned and is currently acquired.
When was Greenphire founded?
Greenphire was founded in 2007. It employs 251 to 500 people.
Where is Greenphire based?
Greenphire is headquartered in King Of Prussia, United States, in the North America region.
How does Greenphire make money?
One revenue line is on record: enterprise SaaS Platform Subscriptions.
Who are Greenphire's main competitors?
Veeva Vault CTMS / eTMF is listed as an others. Broad incumbents are Veeva Systems, IQVIA and Oracle Health Sciences. Emerging players are ArisGlobal, Medrio and Castor. Direct peers are Medidata (Dassault Systèmes), Signant Health and Clario.
Does Greenphire have an API?
No public API is recorded for Greenphire.
What industry is Greenphire in?
Greenphire's product category is Clinical Trial Technology Software. Its primary akta.pro industry code is HLACAOAL, Decentralized/Hybrid Trial Enablement (DCT) Platforms, with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 5415 and its SIC code is 7372.